These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8525861)

  • 21. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.
    Claassen CA; Trivedi MH; Rush AJ; Husain MM; Zisook S; Young E; Leuchter A; Wisniewski SR; Balasubramani GK; Alpert J
    J Affect Disord; 2007 Jan; 97(1-3):77-84. PubMed ID: 16824617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Event-related potentials and suicide behavior in patients with affective disorder].
    Wang J; Chen X; Lou F
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):275-7. PubMed ID: 11798771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictors of suicidal acts after major depression in bipolar disorder: a prospective study.
    Galfalvy H; Oquendo MA; Carballo JJ; Sher L; Grunebaum MF; Burke A; Mann JJ
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):586-95. PubMed ID: 17042832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression.
    Ansseau M; Von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ
    Br J Psychiatry; 1988 Jul; 153():65-71. PubMed ID: 3224252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the medical lethality of suicide attempts in bipolar and major depressive disorders.
    Zalsman G; Braun M; Arendt M; Grunebaum MF; Sher L; Burke AK; Brent DA; Chaudhury SR; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):558-65. PubMed ID: 17042829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affective temperaments, as measured by TEMPS-A, among nonviolent suicide attempters.
    Rihmer A; Rozsa S; Rihmer Z; Gonda X; Akiskal KK; Akiskal HS
    J Affect Disord; 2009 Jul; 116(1-2):18-22. PubMed ID: 19036456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased plasma nitric oxide level associated with suicide attempt in depressive patients.
    Kim YK; Paik JW; Lee SW; Yoon D; Han C; Lee BH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1091-6. PubMed ID: 16725247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attempted suicide and alcohol dependence: results of an epidemiologic survey].
    Chignon JM; Cortes MJ; Martin P; Chabannes JP
    Encephale; 1998; 24(4):347-54. PubMed ID: 9809240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects.
    Hansenne M; Pinto E; Scantamburlo G; Couvreur A; Reggers J; Fuchs S; Pitchot W; Ansseau M
    Hum Psychopharmacol; 2003 Apr; 18(3):201-5. PubMed ID: 12672172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines).
    Hansenne M; Pitchot W; Gonzalez Moreno A; Papart P; Timsit-Berthier M; Ansseau M
    Electroencephalogr Clin Neurophysiol; 1995 Mar; 96(2):194-6. PubMed ID: 7535224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of suicidal behaviour in general practice].
    Vörös V; Osváth P; Ruzsics I; Nagy T; Kovács L; Varga J; Fekete S; Kovács A
    Orv Hetil; 2006 Feb; 147(6):263-8. PubMed ID: 16610617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
    Baumann MH; Milchanowski AB; Rothman RB
    Neuroscience; 2004; 125(3):683-90. PubMed ID: 15099682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low plasma BDNF is associated with suicidal behavior in major depression.
    Kim YK; Lee HP; Won SD; Park EY; Lee HY; Lee BH; Lee SW; Yoon D; Han C; Kim DJ; Choi SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):78-85. PubMed ID: 16904252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of total serum cholesterol in the evaluation of suicidal risk.
    Olié E; Picot MC; Guillaume S; Abbar M; Courtet P
    J Affect Disord; 2011 Sep; 133(1-2):234-8. PubMed ID: 21521628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family history of suicidal behavior and earlier onset of suicidal behavior.
    Roy A
    Psychiatry Res; 2004 Dec; 129(2):217-9. PubMed ID: 15590049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
    Kimber J; Sivenandan M; Watson L; Mathias CJ
    Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State and trait anxiety in adolescent suicide attempters.
    Ohring R; Apter A; Ratzoni G; Weizman R; Tyano S; Plutchik R
    J Am Acad Child Adolesc Psychiatry; 1996 Feb; 35(2):154-7. PubMed ID: 8720624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panic disorder and suicidality: is comorbidity with depression the key?
    Diaconu G; Turecki G
    J Affect Disord; 2007 Dec; 104(1-3):203-9. PubMed ID: 17442399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.